Temporal changes in glucose homeostasis and incretin hormone response at 1 and 6 months after laparoscopic sleeve gastrectomy

Surgery for Obesity and Related Diseases

Volumn 10, Issue 5, 2014, Pages 860-869

  Mallipedhi, Akhila ^a,b   Prior, Sarah L ^a   Barry, Jonathan D ^b   Caplin, Scott ^b   Baxter, John N ^b   Stephens, Jeffrey W ^a,b  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b ABERTAWE BRO MORGANNWG UNIVERSITY HEALTH BOARD   (United Kingdom)

Author keywords

Biliopancreatic diversion; Obesity; Sleeve gastrectomy; Type 2 diabetes mellitus

Indexed keywords

C PEPTIDE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; INCRETIN; INSULIN; ORAL ANTIDIABETIC AGENT; CHOLESTEROL; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; TRIACYLGLYCEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BARIATRIC SURGERY; BODY MASS; CLINICAL ARTICLE; DIET THERAPY; FEMALE; GLUCOSE HOMEOSTASIS; HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN CLEARANCE; INSULIN SENSITIVITY; LAPAROSCOPIC SLEEVE GASTRECTOMY; LAPAROSCOPIC SURGERY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SLEEVE GASTRECTOMY; BILIOPANCREATIC BYPASS; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; GASTRECTOMY; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; LAPAROSCOPY; LIPID METABOLISM; METABOLISM; MIDDLE AGED; OBESITY, MORBID; PHYSIOLOGY; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROCEDURES;

BARIATRIC SURGERY; BILIOPANCREATIC DIVERSION; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRECTOMY; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE 1; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; HUMANS; INCRETINS; INSULIN; INSULIN RESISTANCE; LAPAROSCOPY; LIPID METABOLISM; MALE; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 84928400340     PISSN: 15507289     EISSN: 18787533     Source Type: Journal    
DOI: 10.1016/j.soard.2014.02.038     Document Type: Article

References (26)

1. Buchwald H, Avidor Y, Braunwald E., et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292:1724-37.
2. Kashyap SR, Daud S, Kelly K.R., et al. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulino-tropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond) 2010; 34:462-71.
3. Rodieux F, Giusti V, D'Alessio DA, Suter M, Tappy L. Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity (Silver Spring) 2008; 16:298-305.
4. Falken Y, Hellstrom PM, Holst J.J., Naslund E. Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. J Clin Endocrinol Metab 2011; 96:2227-35.
5. Dirksen C, Jorgensen NB, Bojsen-Moller KN, et al. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Diabetologia 2012; 55:1890-901.
6. Pories WJ, Swanson MS, MacDonald K.G., et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus Ann Surg 1995; 222:339-50. (discussion 50-2).
7. Alam I, Stephens JW, Fielding A, Lewis K.E., Lewis MJ, Baxter JN. Temporal changes in glucose and insulin homeostasis after bilio-pancreatic diversion and laparoscopic adjustable gastric banding. Surg Obes Relat Dis 2012; 8:752-63.
8. Papamargaritis D, le Roux CW, Sioka E, Koukoulis G, Tzovaras G., Zacharoulis D. Changes in gut hormone profile and glucose homeo-stasis after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis 2013; 9:192-201.
9. Benaiges D, Flores Le-Roux JA, Pedro-Botet J, et al. Sleeve gastrectomy and Roux-en-Y gastric bypass are equally effective in correcting insulin resistance. Int J Surg 2013; 11:309-13.
10. Tsoli M, Chronaiou A, Kehagias I., Kalfarentzos F, Alexandrides TK. Hormone changes and diabetes resolution after biliopancreatic diversion and laparoscopic sleeve gastrectomy: a comparative prospective study. Surg Obes Relat Dis 2013; 9:667-77.
11. Cohen RV, Pinheiro JC, Schiavon C.A., Salles JE, Wajchenberg BL, Cummings DE. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 2012; 35:1420-8.
12. Carey DG, Jenkins AB, Campbell L.V., Freund J., Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 1996; 45:633-8.
13. Leonetti F, Capoccia D, Coccia F., et al. Obesity, type 2 diabetes mellitus, and other comorbidities: a prospective cohort study of laparoscopic sleeve gastrectomy vs medical treatment. Arch Surg 2012; 147:694-700.
14. Jimenez A, Casamitjana R, Flores L., et al. Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects. Ann Surg 2012; 256:1023-9.
15. Meier JJ, Nauck MA. Glucagon-like peptide 1(GLP-1) in biology and pathology. Diabetes Metab Res Rev 2005; 21:91-117.
16. Standards of medical care in diabetes. Diabetes Care 2013; 36:S11-66.
17. Wolever TM, Chiasson JL, Csima A, et al. Variation of postprandial plasma glucose, palatability, and symptoms associated with a standardized mixed test meal versus 75 g oral glucose. Diabetes Care 1998; 21:336-40.
18. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998; 21:2191-2.
19. Uwaifo GI, Fallon EM, Chin J, Elberg J., Parikh SJ, Yanovski JA. Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children. Diabetes Care 2002; 25:2081-7.
20. Bojsen-Moller KN, Dirksen C, Jorgensen N.B., et al. Increased hepatic insulin clearance after Roux-en-Y Gastric Bypass. J Clin Endocrinol Metab 2013; 98:E1066-71. (2013).
21. Deitel M, Crosby RD, Gagner M. The first International Consensus Summit for sleeve gastrectomy (SG), New York City, October 25-27, 2007. Obes Surg 2008; 18:487-96.
22. Gumbs AA, Gagner M, Dakin G., Pomp A. Sleeve gastrectomy for morbid obesity. Obes Surg 2007; 17:962-9.
23. Rao RS, Kini S. GIP and bariatric surgery. Obes Surg 2011; 21:244-52.
24. Sarkhosh K, Birch DW, Shi X, Gill R.S., Karmali S. The impact of sleeve gastrectomy on hypertension: a systematic review. Obes Surg 2012; 22:832-7.
25. Abbatini F, Rizzello M, Casella G., et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc 2010; 24:1005-10.
26. Harris MI. Diabetes in America: epidemiology and scope of the problem. Diabetes Care 1998; 21:C11-4.